Patient-reported outcomes from STARTRK-2: a global phase II basket study of entrectinib for ROS1 fusion-positive non-small-cell lung cancer and NTRK fusion-positive solid tumours
- Paz-Ares, L.
- Barlesi, F.
- Siena, S.
- Ahn, M.-J.
- Drilon, A.
- Conley, A.
- Rolfo, C.
- Wolf, J.
- Seto, T.
- Doebele, R.
- Kapre, A.
- Chen, D.
- McCallum, S.
- Osborne, S.
- Demetri, G.
ISSN: 2059-7029
Année de publication: 2021
Volumen: 6
Número: 3
Pages: 100113
Type: Article